via The Scientist RSS https://ift.tt/3yLzOhN The FDA pauses the research program on a lentivirus-based treatment for a rare neurological condition after a patient developed a bone marrow disorder that could presage leukemia. https://ift.tt/eA8V8J August 12, 2021 at 11:19PM